Physician
Jha, Pranati
Jha, Pranati was paid $563K by Medicaid between Jan 2018 and Dec 2024, across 24 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 44% of everything it billed.
33Billing provider infoJHA, PRANATI
CUMBERLAND, RI 02864
CUMBERLAND, RI 02864
33aNPI1184887283assigned 07/08/2008
33bProvider typePediatrics Physician
28Total paid$563K
24GClaims11,508
24DCodes billed24
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Rhode Island
Rank by total paid#45 of 265
Median peer was paid$133K
This provider vs. median4.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,865 | $70K | |
| 2019 | 422 | $20K | |
| 2020 | 2,190 | $87K | |
| 2021 | 2,305 | $103K | |
| 2022 | 1,796 | $105K | |
| 2023 | 2,483 | $147K | |
| 2024incomplete | 447 | $30K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 44% | 4,180 | 3,664 | $249K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 1,922 | 1,805 | $153K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 6.4% | 290 | 287 | $36K |
| 92587 | 4.7% | 482 | 466 | $26K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.2% | 1,229 | 1,180 | $18K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.0% | 202 | 196 | $17K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.2% | 213 | 209 | $13K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.1% | 133 | 122 | $12K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.0% | 1,025 | 971 | $11K |
| 97802 | 2.0% | 571 | 550 | $11K | |
| 90461 | <1% | 233 | 220 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 307 | 297 | $3K |
12 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 27 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 168 | $2K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 12 | $1K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 86 | $976.42 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 13 | $934.64 |
| 99177 | <1% | 181 | $802.84 | |
| 96127 | <1% | 80 | $303.66 | |
| 99401 | <1% | 12 | $302.43 | |
| 81002 | <1% | 102 | $228.81 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $195.72 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 14 | $32.87 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 13 | $0.52 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.